| Courtney Fetto, CAA | |
|
1309 N Flagler Dr, West Palm Beach, FL 33401-3406 | |
| (561) 655-5511 | |
| Not Available |
| Full Name | Courtney Fetto |
|---|---|
| Gender | Female |
| Speciality | Anesthesiologist Assistant |
| Location | 1309 N Flagler Dr, West Palm Beach, Florida |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1417365560 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | (* (Not Available)) | Primary |
| Entity Name | Sheridan Healthcorp Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629781711 PECOS PAC ID: 3173429693 Enrollment ID: O20031208000355 |
News Archive
Using cutting-edge imaging technology, researchers at Massachusetts General Hospital (MGH) have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in mitigating the spread of infectious diseases in such settings.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others.
TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
› Verified 8 days ago
| Entity Name | Bay Area Anesthesia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134210040 PECOS PAC ID: 1153385612 Enrollment ID: O20041115000607 |
News Archive
Using cutting-edge imaging technology, researchers at Massachusetts General Hospital (MGH) have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in mitigating the spread of infectious diseases in such settings.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others.
TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
› Verified 8 days ago
| Entity Name | Bethesda Anesthesia Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801054473 PECOS PAC ID: 3971670795 Enrollment ID: O20080920000183 |
News Archive
Using cutting-edge imaging technology, researchers at Massachusetts General Hospital (MGH) have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in mitigating the spread of infectious diseases in such settings.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others.
TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Courtney Fetto, CAA 401 Mangrove Pt, Jupiter, FL 33458-8354 Ph: (229) 322-8497 | Courtney Fetto, CAA 1309 N Flagler Dr, West Palm Beach, FL 33401-3406 Ph: (561) 655-5511 |
News Archive
Using cutting-edge imaging technology, researchers at Massachusetts General Hospital (MGH) have shown that the brains of young men with autism spectrum disorder (ASD) have low levels of a protein that appears to play a role in inflammation and metabolism.
A widespread outbreak of respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) at a long-term dementia care ward infected 73 percent of patients, demonstrating the serious challenges in mitigating the spread of infectious diseases in such settings.
Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM) a rapidly growing provider of specialty medical products, announced today it has closed on its acquisition of Resorbable Orthopedics LLC, a private company with patented technologies including a resorbable bone wax and a delivery system for orthopedic bone void fillers, among others.
TRS Institute (TRSi), the nation's leading provider of AHDI-approved online medical transcription and speech recognition training programs, announces two new courses designed for healthcare documentation professionals, medical transcriptionists, and allied health professionals. The online courses will assist healthcare professionals in honing skills to increase their marketability in the healthcare documentation field.
Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. today announced the companies have begun enrolling patients in a Phase 3 randomized, double-blind, placebo-controlled trial evaluating Nexavar tablets in combination with the oral chemotherapeutic agent, capecitabine, versus placebo plus capecitabine for the treatment of patients with advanced breast cancer.
› Verified 8 days ago
Michael A. Imon, AA-C Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 2201 45th Street, West Palm Beach, FL 33407 Phone: 954-838-2371 Fax: 954-851-1758 | |
Alexandra Bain, AA-C Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 901 45th St, West Palm Beach, FL 33407 Phone: 561-623-2064 | |
Megan Grace Busman, PA-A Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 561-655-5511 | |
Mrs. Danielle Rose Biancardi, CAA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 1309 N Flagler Dr, West Palm Beach, FL 33401 Phone: 786-492-2382 | |
Andre Eduardo Boz, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 901 45th St, West Palm Beach, FL 33407 Phone: 305-693-6100 | |
Erik C Nelson, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 2201 45th St, West Palm Beach, FL 33407 Phone: 561-863-3970 Fax: 954-514-3960 |